AAAAAA

   
Results: 1-15 |
Results: 15
DOXORUBICIN PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENTS IN EL4-LYMPHOMA-BEARING C57BL 6 MICE/
Authors: EHRKE MJ VERSTOVSEK S UJHAZY P MEER JM EPPOLITO C MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., DOXORUBICIN PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENTS IN EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 45(6), 1998, pp. 287-298
RECRUITMENT OF CANALICULAR MEMBRANE-PROTEINS AND MODULATION BY TAUROCHOLATE, COLCHICINE AND WORTMANNIN IN RAT-LIVER
Authors: UJHAZY P MISRA S GATMAITAN Z VARTICOVSKI L ARIAS IM
Citation: P. Ujhazy et al., RECRUITMENT OF CANALICULAR MEMBRANE-PROTEINS AND MODULATION BY TAUROCHOLATE, COLCHICINE AND WORTMANNIN IN RAT-LIVER, Hepatology, 28(4), 1998, pp. 1044-1044
THE ROLE OF PHOSPHOINOSITIDE 3-KINASE IN TAUROCHOLATE-INDUCED TRAFFICKING OF ATP-DEPENDENT CANALICULAR TRANSPORTERS IN RAT-LIVER
Authors: MISRA S UJHAZY P GATMAITAN Z VARTICOVSKI L ARIAS IM
Citation: S. Misra et al., THE ROLE OF PHOSPHOINOSITIDE 3-KINASE IN TAUROCHOLATE-INDUCED TRAFFICKING OF ATP-DEPENDENT CANALICULAR TRANSPORTERS IN RAT-LIVER, The Journal of biological chemistry, 273(41), 1998, pp. 26638-26644
THYMIC ANTITUMOR EFFECTORS IN MICE CURED OF LYMPHOMA BY CYCLOPHOSPHAMIDE PLUS TNF-ALPHA THERAPY - PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION UP TO 20 MONTHS AFTER INITIAL TUMOR INOCULATION
Authors: EHRKE MJ VERSTOVSEK S POCCHIARI SK KRAWCZYK CM UJHAZY P ZALESKIS G MACCUBBIN DL MEER JM MIHICH E
Citation: Mj. Ehrke et al., THYMIC ANTITUMOR EFFECTORS IN MICE CURED OF LYMPHOMA BY CYCLOPHOSPHAMIDE PLUS TNF-ALPHA THERAPY - PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION UP TO 20 MONTHS AFTER INITIAL TUMOR INOCULATION, International journal of cancer, 76(4), 1998, pp. 579-586
PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE (VOL 40, PG 347, 1995)/
Authors: KRAWCZYK CM VERSTOVSEK S UJHAZY P MACCUBBIN D EHRKE MJ
Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE (VOL 40, PG 347, 1995)/, Cancer immunology and immunotherapy, 45(1), 1997, pp. 60-60
EXPRESSION OF B-CELL MARKERS ON SR-4987 CELLS DERIVED FROM MURINE BONE-MARROW STROMA
Authors: PESSINA A NERI MG MINEO E PICCIRILLO M GRIBALDO L BRAMBILLA P ZALESKIS G UJHAZY P
Citation: A. Pessina et al., EXPRESSION OF B-CELL MARKERS ON SR-4987 CELLS DERIVED FROM MURINE BONE-MARROW STROMA, Experimental hematology, 25(6), 1997, pp. 536-541
SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2
Authors: EHRKE MJ VERSTOVSEK S ZALESKIS G HO RLX UJHAZY P MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(4), 1996, pp. 221-230
EVIDENCE FOR THE INVOLVEMENT OF ECTO-5-NUCLEOTIDASE (CD73) IN DRUG-RESISTANCE
Authors: UJHAZY P BERLETH ES PIETKIEWICZ JM KITANO H SKAAR JR EHRKE MJ MIHICH E
Citation: P. Ujhazy et al., EVIDENCE FOR THE INVOLVEMENT OF ECTO-5-NUCLEOTIDASE (CD73) IN DRUG-RESISTANCE, International journal of cancer, 68(4), 1996, pp. 493-500
PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE/
Authors: KRAWCZYK CM VERSTOVSEK S UJHAZY P MACCUBBIN D EHRKE MJ
Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 40(6), 1995, pp. 347-357
MURINE SPLENIC MACROPHAGE TUMORICIDAL ACTIVATION BY CYTOKINES
Authors: VERSTOVSEK S EPPOLITO C UJHAZY P MACCUBBIN DL EHRKE MJ MIHICH E
Citation: S. Verstovsek et al., MURINE SPLENIC MACROPHAGE TUMORICIDAL ACTIVATION BY CYTOKINES, Experimental hematology, 23(6), 1995, pp. 519-528
CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA CHEMOIMMUNOTHERAPY CURED MICE - LIFELONG IMMUNITY AND REJECTION OF RE-IMPLANTED PRIMARY LYMPHOMA
Authors: EHRKE MJ VERSTOVSEK S KRAWCZYK CM UJHAZY P ZALESKIS G MACCUBBIN DL MIHICH E
Citation: Mj. Ehrke et al., CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA CHEMOIMMUNOTHERAPY CURED MICE - LIFELONG IMMUNITY AND REJECTION OF RE-IMPLANTED PRIMARY LYMPHOMA, International journal of cancer, 63(3), 1995, pp. 463-471
TNF-ALPHA POTENTIATION OF THE LYMPHOKINE-ACTIVATED KILLER RESPONSE OFMURINE THYMUS-CELLS
Authors: UJHAZY P MACCUBBIN D EPPOLITO C MIHICH E EHRKE MJ
Citation: P. Ujhazy et al., TNF-ALPHA POTENTIATION OF THE LYMPHOKINE-ACTIVATED KILLER RESPONSE OFMURINE THYMUS-CELLS, Lymphokine and cytokine research, 13(2), 1994, pp. 99-106
INTRACELLULAR DOXORUBICIN KINETICS IN LYMPHOMA-CELLS AND LYMPHOCYTES INFILTRATING THE TUMOR AREA IN-VIVO - A FLOW CYTOMETRIC STUDY
Authors: ZALESKIS G HO RLX DIEGELMAN P MACCUBBIN D UJHAZY P MIHICH E EHRKE MJ
Citation: G. Zaleskis et al., INTRACELLULAR DOXORUBICIN KINETICS IN LYMPHOMA-CELLS AND LYMPHOCYTES INFILTRATING THE TUMOR AREA IN-VIVO - A FLOW CYTOMETRIC STUDY, Oncology research, 6(4-5), 1994, pp. 183-194
ECTO-5'-NUCLEOTIDASE (CD73) IN MULTIDRUG-RESISTANT CELL-LINES GENERATED BY DOXORUBICIN
Authors: UJHAZY P KLOBUSICKA M BABUSIKOVA O STRAUSBAUCH P MIHICH E EHRKE MJ
Citation: P. Ujhazy et al., ECTO-5'-NUCLEOTIDASE (CD73) IN MULTIDRUG-RESISTANT CELL-LINES GENERATED BY DOXORUBICIN, International journal of cancer, 59(1), 1994, pp. 83-93
IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/
Authors: HO RLX MACCUBBIN DL UJHAZY P ZALESKIS G EPPOLITO C MIHICH E EHRKE MJ
Citation: Rlx. Ho et al., IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/, Oncology research, 5(9), 1993, pp. 363-372
Risultati: 1-15 |